CLOs on the Move

Crotched Mountain Foundation

www.cmf.org

 
Crotched Mountain Foundation is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Greenfield, NH. To find more information about Crotched Mountain Foundation, please visit www.cmf.org
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.cmf.org
  • 1 Verney Dr
    Greenfield, NH USA 03047-5000
  • Phone: 603.547.3311

Executives

Name Title Contact Details

Similar Companies

Kluwer Health International

Kluwer Health International is a Bridgewater, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

IntegraCare Home health

IntegraCare Home health is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Grapevine, TX. To find more information about IntegraCare Home health, please visit www.txhmg.com

PTPN

PTPN is a Calabasas, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

USLAB

USLAB is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Versartis

Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.